Licensed Patent Rights

Licensed Patent Rights. All of Halozyme's rights (including Halozyme's grantback rights from third parties to the extent sublicensable) in (a) all patent applications heretofore or hereafter filed that claim or cover PH20 Drug alone or in combination with any other composition, as necessary or useful to develop, obtain regulatory approval for, manufacture, commercialize or use Products in the Licensed Field, (b) all patents that have issued or in the future issue from any of the foregoing patent applications,... including without limitation utility models, design patents and certificates of invention, and (c) all divisionals, continuations, continuations-in-part, reissues, renewals, extensions or additions to any such patents and patent applications. For clarity, Licensed Patents Rights include Collaboration Supported PH20 Patents View More

Licensed Patent Rights. The patents and patent applications list on Exhibit A, together with all patent applications filed during the Term and Controlled by Angiotech that are related to the existing patents and patent applications set out in Exhibit A by way of any continuations, continuations-in-part, divisions or any substitute applications, any patent issued with respect to any such patent applications, any reissue, re-examination, renewal or extension (including any supplemental patent certificate) of any such... patent, and any confirmation patent or registration patent or patent of addition based on any such patent, and all foreign counterparts of any of the foregoing, in each case only to the extent, however, that claims in any patent application filed during the Term are entirely supported in the specification and entitled to the priority date of the parent patent application in Exhibit A View More

Licensed Patent Rights. Shall mean University's rights in and to the Inventions and Improvements covered at any time by United States or foreign patents or patent applications and all divisions, continuations, continuations- in-part, reissues, reexaminations or extensions thereof, and any letters patent that issue thereon.

Licensed Patent Rights. For purposes of this Supplemental Agreement and the 1999 Agreements, Licensed Patent Rights shall mean (a) those certain patents listed on Schedule A of the License to Inhale and all foreign counterpart patent applications and patents claiming priority of such patent applications and patents; (b) all patents and patent applications in any country that claim Licensable Improvements; (c) all patents that have issued or in the future issue from any of the foregoing patent applications, including... utility, model, and design patents and certificates of invention; and (d) all divisionals, continuations, continuations-in-part, reissues, renewals, extensions, or additions of any of the foregoing patent applications and patents; in each case which Alliance now has or in which Alliance hereafter acquires an ownership or licensable interest. View More

Licensed Patent Rights. Shall mean the rights which are held or which come to be held by SCANIS and its successors and assigns by virtue of its ownership of the Licensed Patents.

Licensed Patent Rights. Means all rights in (a) those patents and patent applications set forth in Exhibit A under the heading "Existing Licensed Patent Rights," (b) any patents and patent applications that are filed on inventions Created by one or more employees or agents of the Licensor or any of its subcontractors in the performance of the activities under the Research Agreement; (c) any patents and patent applications that are filed on inventions Created by or in the laboratory, or under the direction, oversight... or supervision, of the PI outside the Research Agreement, where such invention is related to the therapeutic use of cultured corneal endothelial cells or their manufacture, production, storage or formulation, to the extent such patent and patent applications are assigned to KPUM; (d) any patents and patent applications that claim priority to or common priority with, or claiming any invention in, any of the patents or patent applications in clause (a), (b) or (c); (e) any divisional, continuation, continuations-in-part, patents of addition with respect to any of the forgoing patents or patent applications; (f) any patents issuing on such patent applications described in clause (a)-(e), together with any substitutions, registrations, supplementary protection certificates, reissues, reexaminations or extensions of any kind with respect to any of the foregoing; and (g) any United States and foreign counterparts of any such patent applications and patents. Upon request from time to time, the Parties shall update Exhibit A to include all Patent Rights then within the Licensed Patent Rights. View More

Licensed Patent Rights. Shall have that meaning set forth in Exhibit A.

Licensed Patent Rights. Means, collectively, Upstream's, its Affiliate rights in (a) all patent applications heretofore or hereafter filed for or in Japan which claim, and only to the extent they claim, the Licensed Compound, the Product or the manufacture or use thereof to the extent reasonably necessary or useful to research, develop, obtain regulatory approval for or commercialize the Product in Japan, and to have made the Product in accordance with this Agreement for use or sale in Japan, including without... limitation all such rights comprising the Astellas Assets (during the term of this Agreement) (For clarity, the initial Licensed Patent Rights as of the Effective Date shall be set forth in Exhibit B of this Agreement); (b) all patents that have issued or in the future issue from any of the foregoing patent applications, including without limitation utility models, design patents and certificates of invention; and (c) all divisionals, continuations, continuations-in-part, reissues, renewals, extensions or additions to any such patents and patent applications. View More

Licensed Patent Rights. Means any patents and patent applications claiming priority from Phenomix's PCT patent application * * *published as * * * ("* * *") or claiming priority from one or more of the U.S. provisional applications from which * * * claims priority, including any national phase or regional phase patent applications claiming priority from * * * or any other U.S. or foreign patents or patent applications claiming priority thereto. * * * Confidential Information, indicated by ***, has been omitted from... this filing and filed separately with the Securities and Exchange Commission. 2 of 13 View More

Licensed Patent Rights. The patents and patent applications listed on Exhibit A to this Agreement, and all continuations, continuations in part and divisions thereof, and all renewals and foreign counterparts of any of the foregoing.